{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:53:37Z","timestamp":1790787217106,"version":"4.1.0"},"reference-count":30,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T00:00:00Z","timestamp":1754611200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Aust J Dermatology"],"published-print":{"date-parts":[[2025,11]]},"abstract":"ABSTRACT<\/jats:title>\n \n Background<\/jats:title>\n There is limited data on the use of dual or combination biologic therapy in dermatological patients, particularly in psoriasis or with other coexisting dermatological conditions. However, this may be necessary for a small proportion of patients.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n We conducted a retrospective review of 46 patients treated with dual or combination biologic therapy at a single dermatology practice in Sydney, Australia. The patient cohort consisted of 44 patients with psoriasis, 1 patient with hidradenitis suppurativa and 1 patient with a combination of hidradenitis suppurativa and psoriasis.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n Of 46 patients receiving a combination of biological agents, only 1 experienced an adverse effect that did not require cessation of therapy.<\/jats:p>\n <\/jats:sec>\n \n Conclusion<\/jats:title>\n The use of combination biologic therapy may be an option for psoriasis patients with recalcitrant disease, in particular for those with concomitant psoriatic arthritis or other dermatological conditions. However, further studies are warranted to evaluate the efficacy, safety and health economics of this treatment approach.<\/jats:p>\n <\/jats:sec>","DOI":"10.1111\/ajd.14584","type":"journal-article","created":{"date-parts":[[2025,8,9]],"date-time":"2025-08-09T06:47:58Z","timestamp":1754722078000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Retrospective Review on Safety and Efficacy of Combination Biologic Therapy for Psoriasis"],"prefix":"10.1111","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-7110-4868","authenticated-orcid":false,"given":"Nicole Kah Mun","family":"Yoong","sequence":"first","affiliation":[{"name":"Sinclair DIRECT (Dermatology, Investigational Research, Education & Clinical Trials) East Melbourne Victoria Australia"},{"name":"Monash Health Clayton Victoria Australia"},{"name":"School of Medicine and Health, University of New South Wales Sydney New South Wales Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin Lin","family":"Wong","sequence":"additional","affiliation":[{"name":"School of Medicine and Health, University of New South Wales Sydney New South Wales Australia"},{"name":"Department of Dermatology Sutherland Hospital Caringbah New South Wales Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Sullivan","sequence":"additional","affiliation":[{"name":"Department of Dermatology Sutherland Hospital Caringbah New South Wales Australia"},{"name":"Kingsway Dermatology & Aesthetics Miranda New South Wales Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,8,8]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2024.02.036"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2017.03.002"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/cei.13449"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.14270"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.5070\/D31HD646HW"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2014.09.002"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.40579"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2024.03.007"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajd.13676"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.2217\/imt-2020-0203"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-5945-5-9"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.2007.02673.x"},{"issue":"11","key":"e_1_2_8_14_1","first-page":"1089","article-title":"Treatment of Psoriatic Arthritis and Recalcitrant Skin Disease With Combination Therapy","volume":"7","author":"Hamilton T. K.","year":"2008","journal-title":"Journal of Drugs in Dermatology"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.110295"},{"issue":"10","key":"e_1_2_8_16_1","first-page":"1098","article-title":"Combination Use of Ustekinumab With Other Systemic Therapies: A Retrospective Study in a Tertiary Referral Center","volume":"12","author":"Heinecke G. M.","year":"2013","journal-title":"Journal of Drugs in Dermatology"},{"issue":"4","key":"e_1_2_8_17_1","first-page":"394","article-title":"Successful Treatment of Refractory Plaque\u2010Type Psoriasis and Psoriatic Arthritis With Guselkumab and Adalimumab Combination Therapy: A Case Report","volume":"18","author":"Rathod D.","year":"2019","journal-title":"Journal of Drugs in Dermatology"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2018.1515465"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2019.08.015"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-3140"},{"key":"e_1_2_8_21_1","volume-title":"Journal of the European Academy of Dermatology and Venereology","author":"Lima H.","year":"2019"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/dth.15359"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/dth.13498"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2019.1659481"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.611549"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajd.13752"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajd.13743"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ad.2021.02.029"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-022-00851-6"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajd.14019"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/dth.15638"}],"container-title":["Australasian Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ajd.14584","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T23:37:55Z","timestamp":1763681875000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ajd.14584"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,8]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["10.1111\/ajd.14584"],"URL":"https:\/\/doi.org\/10.1111\/ajd.14584","archive":["Portico"],"relation":{},"ISSN":["0004-8380","1440-0960"],"issn-type":[{"value":"0004-8380","type":"print"},{"value":"1440-0960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,8]]},"assertion":[{"value":"2025-03-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-02","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-08","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}